Sanctuary Advisors LLC Acquires 584 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Sanctuary Advisors LLC boosted its holdings in Semler Scientific, Inc. (NASDAQ:SMLR) by 13.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,012 shares of the company’s stock after acquiring an additional 584 shares during the quarter. Sanctuary Advisors LLC owned 0.05% of Semler Scientific worth $261,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SMLR. Quest Partners LLC boosted its position in Semler Scientific by 48.0% in the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after buying an additional 817 shares in the last quarter. US Bancorp DE boosted its position in Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after buying an additional 1,158 shares in the last quarter. GSA Capital Partners LLP boosted its position in Semler Scientific by 73.9% in the third quarter. GSA Capital Partners LLP now owns 10,336 shares of the company’s stock valued at $243,000 after buying an additional 4,393 shares in the last quarter. Verition Fund Management LLC acquired a new position in Semler Scientific in the third quarter valued at about $251,000. Finally, Veery Capital LLC acquired a new position in Semler Scientific in the fourth quarter valued at about $324,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital boosted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Trading Down 1.4 %

Shares of SMLR stock opened at $38.36 on Wednesday. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $81.56. The firm’s 50 day moving average is $53.51 and its 200-day moving average is $43.53. The firm has a market capitalization of $355.48 million, a price-to-earnings ratio of 7.81 and a beta of 1.17.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The company had revenue of $12.41 million for the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.